ValuentumAd

Official PayPal Seal
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Aug 1, 2013
Teva Boasts a Several Billion Dollar NTE Opportunity
Revenue potential from the launch of new therapeutic entities (NTEs) in coming years should more than offset troubles from the loss of exclusivity of Copaxone.
Aug 1, 2013
Regulatory Uncertainty Once Again Strikes Visa and MasterCard
Last time regulatory uncertainty struck it provided a wonderful entry point for Visa. Will history repeat itself?
Jul 31, 2013
Amgen’s Second Quarter Doesn’t Disappoint
Amgen posted a solid second quarter, but we think shares look fairly valued.
Jul 31, 2013
Utilization Drives Record Profit at TAL International
The intermodal container lessor continues to capitalize on its low-risk leasing model despite a modest shipping environment.
Jul 31, 2013
Buffalo Wild Wings’ Second Quarter Was Fantastic
Best Ideas Portfolio holding Buffalo Wild Wings reported another solid quarter, demonstrating the firm’s ability to capitalize on its winning strategy.
Jul 31, 2013
With North America Saturated, Coach Needs International Growth
Coach’s core North American business isn’t growing as quickly as it used to as competitors catch up.
Jul 29, 2013
AbbVie’s Humira Continues to Drive Strong Performance; Pipeline Advances
Humira continues to drive strong performance in the second quarter, while AbbVie's pipeline advances.
Jul 26, 2013
Productivity on the Rise at Starbucks
Same-store sales continue to soar at the coffee house giant.
Jul 26, 2013
Qualcomm Rises on Strong Revenue Growth
Qualcomm easily exceeded top-line estimates. We like the firm, but we would be more interested at a lower price.
Jul 26, 2013
Baidu Surges on Strong Results and Outlook
The Chinese search giant provided results and guidance above consensus estimates.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.